» Articles » PMID: 31105764

Ocular Gene Therapy for Choroideremia: Clinical Trials and Future Perspectives

Overview
Publisher Informa Healthcare
Specialty Ophthalmology
Date 2019 May 21
PMID 31105764
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Gene therapy offers the potential for targeted replacement of single gene defects in inherited retinal degenerations.

Areas Covered: Choroideremia is an X-linked blinding retinal disease resulting from deficiency of the gene product, REP1. The disease represents an ideal target for retinal gene therapy, as it is readily diagnosed in the clinic, relatively homogenous in phenotype and slow progressing, thereby providing a wide therapeutic window for intervention. Ongoing clinical trials of retinal gene therapy for choroideremia using an adeno-associated viral vector have demonstrated safety and early efficacy. We review the clinical characteristics of the disease with a view to interpreting the findings of gene therapy clinical trials and discuss future directions.

Expert Commentary: Choroideremia gene therapy has so far demonstrated good safety profile and early functional visual acuity gains in a proportion of trial participants, which appear to be sustained.

Citing Articles

Ocular Gene Therapy: An Overview of Viral Vectors, Immune Responses, and Future Directions.

Banou L, Sarrafpour S, Teng C, Liu J Yale J Biol Med. 2024; 97(4):491-503.

PMID: 39703610 PMC: 11650918. DOI: 10.59249/HWID7537.


Recombinant adeno-associated virus as a delivery platform for ocular gene therapy: A comprehensive review.

Wang J, Zhan W, Gallagher T, Gao G Mol Ther. 2024; 32(12):4185-4207.

PMID: 39489915 PMC: 11638839. DOI: 10.1016/j.ymthe.2024.10.017.


Evaluating precision medicine approaches for gene therapy in patient-specific cellular models of Bietti crystalline dystrophy.

Li Y, Yang R, Li Y, Hsu C, Jenny L, Kong Y JCI Insight. 2024; 9(16).

PMID: 39171529 PMC: 11343589. DOI: 10.1172/jci.insight.177231.


Whole-exome sequencing identified genes known to be responsible for retinitis pigmentosa in 28 Chinese families.

Shen C, You B, Chen Y, Li Y, Li W, Wei W Mol Vis. 2022; 28:96-113.

PMID: 35814500 PMC: 9239900.


Tropism of AAV Vectors in Photoreceptor-Like Cells of Human iPSC-Derived Retinal Organoids.

McClements M, Steward H, Atkin W, Goode E, Gandara C, Chichagova V Transl Vis Sci Technol. 2022; 11(4):3.

PMID: 35377942 PMC: 8994202. DOI: 10.1167/tvst.11.4.3.


References
1.
Yang G, Schmidt M, Yan Z, Lindbloom J, Harding T, Donahue B . Virus-mediated transduction of murine retina with adeno-associated virus: effects of viral capsid and genome size. J Virol. 2002; 76(15):7651-60. PMC: 136354. DOI: 10.1128/jvi.76.15.7651-7660.2002. View

2.
Anand V, Barral D, Zeng Y, Brunsmann F, Maguire A, Seabra M . Gene therapy for choroideremia: in vitro rescue mediated by recombinant adenovirus. Vision Res. 2003; 43(8):919-26. DOI: 10.1016/s0042-6989(02)00389-9. View

3.
Plotkin J, Robins H, Levine A . Tissue-specific codon usage and the expression of human genes. Proc Natl Acad Sci U S A. 2004; 101(34):12588-91. PMC: 515101. DOI: 10.1073/pnas.0404957101. View

4.
Tolmachova T, Anders R, Abrink M, Bugeon L, Dallman M, Futter C . Independent degeneration of photoreceptors and retinal pigment epithelium in conditional knockout mouse models of choroideremia. J Clin Invest. 2006; 116(2):386-94. PMC: 1326146. DOI: 10.1172/JCI26617. View

5.
Allocca M, Mussolino C, Garcia-Hoyos M, Sanges D, Iodice C, Petrillo M . Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors. J Virol. 2007; 81(20):11372-80. PMC: 2045569. DOI: 10.1128/JVI.01327-07. View